drugset / Trial / NCT06054984

TCR-T Cells in the Treatment of Advanced Pancreatic Cancer

NCT06054984 ↗

NaSingle-groupOpen-labelTreatment

Summary

To investigate the safety, tolerability, efficacy and pharmacokinetics of TCR-T cells in the treatment of advanced pancreatic cancer

Timeline

Start
2021-09-07
Primary completion
2024-06-07
Completion
2024-09-07

Drugs

EvaluationDrugModalityDoseRoute
Subject GB3010 Cell therapy 5e+08 cells Intravenous
Subject GB3010 Cell therapy 5e+09 cells Intravenous
Subject GB3010 Cell therapy 5e+10 cells Intravenous